Genzyme, IG Laboratories Inc. deal

IGLI's independent shareholders approved the previously announced merger of IGLI and GENZ (see BioCentury May 22). Before the merger GENZ owns 70 percent (6.4 million shares) of the Cambridge, Mass., ...